WINTER HONIG PEUZIAT: Open Payments
NPI 1609241553 · FREDERICKSBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 13 payments from 9 companies in 2025. Trend: 2023 $26 · 2024 $329 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $149 |
| Lilly USA, LLC | 2 | $61 |
| PFIZER INC. | 3 | $59 |
| SI-BONE, INC. | 1 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| ARGENX US, INC. | 1 | $15 |
Products named: Ozempic, JARDIANCE, PAXLOVID, Rybelsus, Kerendia, REXULTI, REPATHA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
